Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Severe acute respiratory syndrome (SARS-CoV2)"'
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss , Pp 110891- (2021)
Severe acute respiratory syndrome (SARS) develops within 3–14 days when CoV2 invades epithelial, myeloid cells in the nasopharynx and pneumocytes in the respiratory tract through angiotensin converting enzyme (ACE2). Infection swiftly disseminates
Externí odkaz:
https://doaj.org/article/3fbf98e28d5b4de98085859900532c02
Autor:
Ankush Kawali, Padmamalini Mahendradas, Rohit Shetty, Srinivasan Sanjay, Sunil Gowda, Deepashri Mutalik
Publikováno v:
Sn Comprehensive Clinical Medicine
Coronavirus disease (COVID-19) can be associated with ophthalmic manifestations like conjunctivitis, retinal haemorrhages, retinal vascular occlusions, papillophlebitis, and Adie's syndrome. We herein report for a case of a unilateral acute anterior
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::021eb3236afcbc918c0105866edd2b57
http://europepmc.org/articles/PMC8184259
http://europepmc.org/articles/PMC8184259
Publikováno v:
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 110891-(2021)
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 110891-(2021)
Graphical abstract
Highlights • SARS-CoV2 virus develops infection within 3-14 days in the respiratory tract • Chloroquine, hydroxychloroquine, noscapine, Remedesivir may be explored in SARS-CoV2 virus infection • Vitamin C and D may also
Highlights • SARS-CoV2 virus develops infection within 3-14 days in the respiratory tract • Chloroquine, hydroxychloroquine, noscapine, Remedesivir may be explored in SARS-CoV2 virus infection • Vitamin C and D may also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec3b23c43f65ca05cb7ea2874e248ed9
http://europepmc.org/articles/PMC7572089
http://europepmc.org/articles/PMC7572089
Publikováno v:
Multiple Sclerosis and Related Disorders
Highlights • SARS-CoV2 pandemic affects daily life of people, negatively. • Children with MS seem to be more affected in terms of anxiety symptoms due to their susceptibility to anxiety. • Establishment of separate health centers to be used dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5e10bc7333394ddc6c6107dd8d8fc55
https://doi.org/10.1016/j.msard.2020.102595
https://doi.org/10.1016/j.msard.2020.102595
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sanjay S; Department of Uvea and Ocular Immunology, Naryana Nethralaya, Bangalore, India., Mutalik D; Department of Uvea and Ocular Immunology, Naryana Nethralaya, Bangalore, India., Gowda S; Department of Ear, Nose and Throat, St Martha's Hospital, Bangalore, India., Mahendradas P; Department of Uvea and Ocular Immunology, Naryana Nethralaya, Bangalore, India., Kawali A; Department of Uvea and Ocular Immunology, Naryana Nethralaya, Bangalore, India., Shetty R; Department of Neuro-ophthalmology, Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.
Publikováno v:
SN comprehensive clinical medicine [SN Compr Clin Med] 2021; Vol. 3 (9), pp. 1843-1847. Date of Electronic Publication: 2021 Jun 07.